Literature DB >> 21142843

Liquid chromatographic-electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain.

Andreas Lehner1, Margaret Johnson, Tyrell Simkins, Kelly Janis, Keith Lookingland, John Goudreau, Wilson Rumbeiha.   

Abstract

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is widely used as a neurotoxin in several models of Parkinson's disease in mice. MPTP is metabolized to 1-methyl-4-phenylpyridinium (MPP(+)), which is a mitochondrial toxicant of central dopamine (DA) neurons. There are species, strain, and age differences in sensitivity to MPTP. Simultaneous measurement of the MPTP active metabolite MPP(+) and dopamine (DA) in the brain would be helpful in mechanistic studies of this neurotoxin. The objective of this study was to develop a liquid chromatography-mass spectrometry (LC/MS) method for analysis of MPTP and MPP(+) in brain tissue and correlate these in the same sample with changes in DA measured via HPLC coupled with electrochemical detection. Twenty-five C57BL/6J7 8-week old female mice were used in the study. Mice were given a single subcutaneous injection of MPTP (20 mg/kg) and were sacrificed 1, 2, 4, or 8 h later. Zero time control mice received an injection of 0.9% normal saline (10 ml/kg) and were killed 1 h later. Brains were rapidly harvested and quickly frozen, and microdissected brain regions were placed in 0.1 M phosphate-citric acid buffer containing 20% methanol (pH 2.5). A new LC/MS method was successfully developed that utilized selected reaction monitoring (SRM) of MPP(+) m/z 170→127, 170→128, and 170→154 fragmentation for quantitation and area ratios (m/z 127)/(m/z 128) and (m/z 154)/(128) for identity confirmation. A similar SRM strategy from m/z 174 was unable to detect any significant levels of MPTP down to 0.4 ppb. According to this method, MPP(+) was detected in the nucleus accumbens (NA) and the striatum (ST), with the levels in the NA being 3-times higher than those in the ST. The advantage of this approach is that the tissue buffer used in this procedure allowed concurrent measurement of striatal DA, thus enabling direct correlation between accumulation of tissue MPP(+) and depletion of DA concentrations in discrete regions of the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142843      PMCID: PMC3363357          DOI: 10.3109/15376516.2010.538753

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  26 in total

1.  Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.

Authors:  A Giovanni; B A Sieber; R E Heikkila; P K Sonsalla
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

2.  Isolated removal of hypothalamic or other brain nuclei of the rat.

Authors:  M Palkovits
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

3.  Sensitive and selective liquid chromatography/tandem mass spectrometry methods for quantitative analysis of 1-methyl-4-phenyl pyridinium (MPP+) in mouse striatal tissue.

Authors:  Mei-Yi Zhang; Natasha Kagan; Mei-Li A Sung; Margaret M Zaleska; Michael Monaghan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-16       Impact factor: 3.205

4.  Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors:  G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

5.  Quantification of Paraquat, MPTP, and MPP+ in brain tissue using microwave-assisted solvent extraction (MASE) and high-performance liquid chromatography-mass spectrometry.

Authors:  Bozena Winnik; Dana B Barr; Mona Thiruchelvam; M Angela Montesano; Eric K Richfield; Brian Buckley
Journal:  Anal Bioanal Chem       Date:  2009-07-19       Impact factor: 4.142

6.  Characterization and relative ionization efficiencies of end-functionalized polystyrenes by matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Frederick J Cox; Murray V Johnston; Arnab Dasgupta
Journal:  J Am Soc Mass Spectrom       Date:  2003-06       Impact factor: 3.109

7.  Strain-specific sensitivity to MPTP of C57BL/6 and BALB/c mice is age dependent.

Authors:  Nikolay M Filipov; Allison B Norwood; Shannon C Sistrunk
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

8.  Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.

Authors:  Modupe O Ogunrombi; Sarel F Malan; Gisella Terre'Blanche; Kay Castagnoli; Neal Castagnoli; Jacobus J Bergh; Jacobus P Petzer
Journal:  Life Sci       Date:  2007-06-28       Impact factor: 5.037

9.  Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death.

Authors:  M Takada; Z K Li; T Hattori
Journal:  Brain Res       Date:  1990-02-12       Impact factor: 3.252

10.  Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult.

Authors:  B Behrouz; R E Drolet; Z A Sayed; K J Lookingland; J L Goudreau
Journal:  Neuroscience       Date:  2007-06-20       Impact factor: 3.590

View more
  4 in total

1.  Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

Authors:  Matthew Benskey; Bahareh Behrouz; Johan Sunryd; Samuel S Pappas; Seung-Hoon Baek; Marianne Huebner; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2012-02-09       Impact factor: 4.294

2.  Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.

Authors:  Tyrell J Simkins; Kelly L Janis; Alison K McClure; Bahareh Behrouz; Samuel S Pappas; Andreas Lehner; Norbert E Kaminski; John L Goudreau; Keith J Lookingland; Barbara L F Kaplan
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-27       Impact factor: 4.147

3.  MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain.

Authors:  Hanane Kadar; Gael Le Douaron; Majid Amar; Laurent Ferrié; Bruno Figadère; David Touboul; Alain Brunelle; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2013-12-18       Impact factor: 3.911

4.  Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-β-carboline by oxidative enzymes.

Authors:  Tomás Herraiz; Hugo Guillén; Juan Galisteo
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.